Deep Dive: Adeno-Associated Virus Delivery 25 years ago, AAV had almost no industry interest. Today, it's a biotech game-changer! With a 39% surge in VC investment in 2021, AAV companies are booming globally, promising curative treatments. Read more: buff.ly/4eWXOUE

Builders w/ Peter Smith - President & CEO @ Remix Therapeutics Join us as Peter, shares insights on reprogramming RNA processing to combat complex diseases. Discover the origin story, innovative approaches, & future vision of Remix Therapeutics. Tune in: buff.ly/3xJoacb

Deep Dive: DNA Writing 🧬 From next-gen sequencing to CRISPR, DNA reading & editing have revolutionized biotech. DNA writing is the next leap. Learn how it will advance gene therapy & synthetic biology in this article. Read more: buff.ly/3zMEGsB

Builders w/ Ivan Dimov - CEO @ Orca Bio 🚀Join us for an insightful talk with Ivan! Discover the origins of Orca Bio, their innovative high-precision cell therapies & the future of cell therapy manufacturing. Tune into: buff.ly/4d6uwBl

Deep Dive: Quantum Aided Drug Development The Quantum Leap in Drug Discovery! Explore how #QuantumComputing will revolutionize #Pharma by enhancing molecular simulations & speeding drug development. Is quantum supremacy within our reach? Read more here: buff.ly/46mnF4H

Builders w/ Dr. Paul Peter Tak - @ Candel Therapeutics 🚀 Join us for a fascinating chat with Paul, CEO of Candel Therapeutics! Discover their novel ‘in-situ vaccination’ platform, pioneering work in viral immunotherapies, & the future of precision medicine. Tune in: buff.ly/46ljWUG

Whole Organ Engineering w/ Gordana Vunjak @ Columbia Join us with Dr. Gordana (Gordana Vunjak-Novakovic) in exploring tissue engineering's future. From multi-organ chip technologies to biomaterial scaffolds, delve into biotech & regenerative medicine insights. Tune in: buff.ly/3Wp8K4V

Deep Dive: Cell-Free Systems 🔬 Cell-free systems are unlocking new possibilities in biopharma! From E. coli lysates to rabbit reticulocytes, explore the diverse applications in producing monoclonal antibodies, enzymes, ADCs, and RNA. 🧬🔍 Read more: buff.ly/3WXBbbX

🧱 Builders w/ Nabiha Saklayen CEO @ Cellino How is Cellino revolutionizing cell therapy? Discover their platform combining label-free imaging, high-speed laser editing & ML to automate cell reprogramming, expansion & differentiation. Tune in: buff.ly/3LR7XoD

Quantum Diagnostics w/ Dino Di Carlo @ UCLA 🎙️ Dive into the future of bioengineering w/ Dino( dinodicarlo)! From inertial microfluidics to smart biomaterials, mechanomedicine, & quantum diagnostics, discover groundbreaking research & more! Tune in: buff.ly/3SE7qKq

Viral Vector Manufacturing Gene & cell therapies face high costs & low supply of viral vectors. Efficient cell lines from synthetic biology could solve this, reducing costs and increasing supply. Discover the future of viral vector production. Read more: buff.ly/3YJCvQZ

Builders w/ Fabian Gerlinghaus @ Cellares From the high costs of autologous cell therapy to early R&D acceleration, Fabian Gerlinghaus of @Cellares covers it all. Learn how their technology is set to transform biomanufacturing. Tune in: buff.ly/3AmLJbw

Supramolecular Biomaterials w/ Eric Appel Delve into Eric's work on drug formulations & excipients, & Surf Bio's progress in protein therapeutics like insulin. Explore his research on supramolecular interactions & their impact on drug delivery. Tune in: buff.ly/4ckvrxa

Deep Dive: Organoids #Organoids: The Future of Medicine! These 3D cell cultures from stem cells replicate human organs, revolutionizing #DrugDevelopment & #RegenerativeMedicine. Learn how they're improving pre-clinical models & reducing costs. Read more: buff.ly/4cr2IH1

🧱 Builders w/ Eric Kelsic @ Dyno Therapeutics Join us as we explore the future of gene therapies with Eric Kelsic (he/him). Learn about Dyno Therapeutics, Inc.’s CapsidMap™ platform, the impact of ML on viral vector development, & what lies ahead for the field. Tune in: buff.ly/3M86oCQ

Advanced Microfluidics✨ w/ Albert Folch @ UW 🎧 Dive into the fascinating world of microfluidic devices with expert Albert Folch! Discover how his team is advancing these devices through automation, improving efficiency & precision. Tune in: buff.ly/4dvcQQe

Deep Dive: Longevity Therapeutics 🧬 Unity Biotech’s Phase II osteoarthritis compound is paving the way for the future of senolytics. Discover more about the latest in longevity therapeutics! #Senolytics #Osteoarthritis #Longevity Read more: buff.ly/3WhflhT

🧱 Builders w/ Maddison Masaeli @ Deepcell Dive deep with Maddison as she explains Deepcell's core competencies. Learn why single-cell imaging & analysis are crucial, & how their innovative tech tackles significant challenges. Tune in: buff.ly/4dZ8tNr

Deep Dive: Drug Repurposing & Reengineering #DrugRepurposing offers a low-cost, low-risk path for drug development. Many compounds can jump straight to Phase II trials! Explore how biopharma unlocks new potentials with old drugs. #Pharma Read more: buff.ly/474ObzQ

🎙️ Biophysics and Rejuvenation w/ Stephen Quake Tune in to hear Stephen Quake discuss the promise of liquid biopsies for early cancer detection, lessons from Theranos, & his efforts with Veblen & Eleftheria to tackle global health challenges. Tune in: buff.ly/3AU0suF